DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyrrolidinesPyrrolidines
  6. /FirazorextonFirazorexton
Chemical structure of CAS 2274802-95-6

Firazorexton

In Stock•Starting at $80 for 1 mg•Purity ≥ 98%
CAS No.2274802-95-6
MDL No.N/A
MFC22H25F3N2O4S
MW470.50
InChI KeyVOSAWOSMGPKQEQ-OALUTQOASA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$80In Stock
5 mg98%$271In Stock
10 mg98%$405In Stock
25 mg98%$688In Stock
50 mg98%$1166In Stock
100 mg98%$1980In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2274802-95-6
Product NameFirazorexton
Heavy Atom Count32Rotatable Bond Count6
Atom Stereo Count2Bond Stereo Count0
HBA4HBD2
TPSA86.710 ŲCharge0
Exact Mass470.14871Complexity1112.23
pKa7.130XLogP2.603

Related Articles

Studies related to this compound and its mechanism of action

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.

The New England journal of medicine • Vol. 389, Issue 4 • 2023
PMID: 37494485DOI: 10.1056/NEJMoa2301940

TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.

The Journal of pharmacology and experimental therapeutics • Vol. 385, Issue 3 • 2023
PMID: 37001988DOI: 10.1124/jpet.122.001449

Documentation

Similar Products

  • Oveporexton

    CAS No.2460722-04-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact